Filing Details
- Accession Number:
- 0001213900-20-044061
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-22 16:03:19
- Reporting Period:
- 2020-12-18
- Accepted Time:
- 2020-12-22 16:03:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1522602 | Cohbar Inc. | CWBR | Pharmaceutical Preparations (2834) | 261299952 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1627971 | Francis Jeffrey Biunno | C/O Cohbar, Inc. 1455 Adams Drive, Suite 2050 Menlo Park CA 94025 | Cfo, Treasurer And Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-12-18 | 7,490 | $0.00 | 17,490 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock Warrants (Right to buy) | Acquisiton | 2020-12-18 | 5,618 | $0.00 | 5,618 | $1.44 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,618 | 2021-06-18 | 2026-06-18 | No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,000 | Indirect | By daughter |
Footnotes
- The reported securities are included within Units purchased by the Reporting Person for $1.22 per Unit upon conversion of a Promissory Note held by the Reporting Person. Each Unit consists of one share of the Issuer's common stock and one warrant to purchase 0.75 of one share of the Issuer's common stock at an exercise price of $1.44.
- Consists of previously reported shares indirectly beneficially owned by the Reporting Person.
Billionaire Hedge Funds
